208 related articles for article (PubMed ID: 29474831)
1. Comparative genomic analysis of Rickettsia rickettsii for identification of drug and vaccine targets: tolC as a proposed candidate for case study.
Maurya PK; Singh S; Mani A
Acta Trop; 2018 Jun; 182():100-110. PubMed ID: 29474831
[TBL] [Abstract][Full Text] [Related]
2. Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host.
Alhassan A; Liu H; McGill J; Cerezo A; Jakkula LUMR; Nair ADS; Winkley E; Olson S; Marlow D; Sahni A; Narra HP; Sahni S; Henningson J; Ganta RR
Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30396898
[TBL] [Abstract][Full Text] [Related]
3. Enhanced protection against Rickettsia rickettsii infection in C3H/HeN mice by immunization with a combination of a recombinant adhesin rAdr2 and a protein fragment rOmpB-4 derived from outer membrane protein B.
Gong W; Wang P; Xiong X; Jiao J; Yang X; Wen B
Vaccine; 2015 Feb; 33(8):985-92. PubMed ID: 25597943
[TBL] [Abstract][Full Text] [Related]
4. Rickettsia rickettsii outer membrane protein YbgF induces protective immunity in C3H/HeN mice.
Gong W; Qi Y; Xiong X; Jiao J; Duan C; Wen B
Hum Vaccin Immunother; 2015; 11(3):642-9. PubMed ID: 25714655
[TBL] [Abstract][Full Text] [Related]
5. Failure of a heterologous recombinant Sca5/OmpB protein-based vaccine to elicit effective protective immunity against Rickettsia rickettsii infections in C3H/HeN mice.
Riley SP; Cardwell MM; Chan YG; Pruneau L; Del Piero F; Martinez JJ
Pathog Dis; 2015 Dec; 73(9):ftv101. PubMed ID: 26519448
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic Cleavage of the Immunodominant Outer Membrane Protein rOmpA in Rickettsia rickettsii.
Noriea NF; Clark TR; Mead D; Hackstadt T
J Bacteriol; 2017 Mar; 199(6):. PubMed ID: 28031280
[No Abstract] [Full Text] [Related]
7. A recombinant Rickettsia conorii vaccine protects guinea pigs from experimental boutonneuse fever and Rocky Mountain spotted fever.
Vishwanath S; McDonald GA; Watkins NG
Infect Immun; 1990 Mar; 58(3):646-53. PubMed ID: 2106490
[TBL] [Abstract][Full Text] [Related]
8. Genomic comparison of virulent Rickettsia rickettsii Sheila Smith and avirulent Rickettsia rickettsii Iowa.
Ellison DW; Clark TR; Sturdevant DE; Virtaneva K; Porcella SF; Hackstadt T
Infect Immun; 2008 Feb; 76(2):542-50. PubMed ID: 18025092
[TBL] [Abstract][Full Text] [Related]
9. Targeted knockout of the Rickettsia rickettsii OmpA surface antigen does not diminish virulence in a mammalian model system.
Noriea NF; Clark TR; Hackstadt T
mBio; 2015 Mar; 6(2):. PubMed ID: 25827414
[TBL] [Abstract][Full Text] [Related]
10. Rocky Mountain spotted fever vaccine: a regional need.
Walker DH; Montenegro MR; Hegarty BC; Tringali GR
South Med J; 1984 Apr; 77(4):447-9. PubMed ID: 6424239
[TBL] [Abstract][Full Text] [Related]
11. Genetic sequencing of a 1944 Rocky Mountain spotted fever vaccine.
Xiao Y; Beare PA; Best SM; Morens DM; Bloom ME; Taubenberger JK
Sci Rep; 2023 Mar; 13(1):4687. PubMed ID: 36949107
[TBL] [Abstract][Full Text] [Related]
12. Immunization with a portion of rickettsial outer membrane protein A stimulates protective immunity against spotted fever rickettsiosis.
Crocquet-Valdes PA; Díaz-Montero CM; Feng HM; Li H; Barrett AD; Walker DH
Vaccine; 2001 Dec; 20(5-6):979-88. PubMed ID: 11738766
[TBL] [Abstract][Full Text] [Related]
13. Surface protein Adr2 of Rickettsia rickettsii induced protective immunity against Rocky Mountain spotted fever in C3H/HeN mice.
Gong W; Xiong X; Qi Y; Jiao J; Duan C; Wen B
Vaccine; 2014 Apr; 32(18):2027-33. PubMed ID: 24582636
[TBL] [Abstract][Full Text] [Related]
14. Infrequency of Rickettsia rickettsii in Dermacentor variabilis removed from humans, with comments on the role of other human-biting ticks associated with spotted fever group Rickettsiae in the United States.
Stromdahl EY; Jiang J; Vince M; Richards AL
Vector Borne Zoonotic Dis; 2011 Jul; 11(7):969-77. PubMed ID: 21142953
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of
Blanton LS; Wilson NM; Quade BR; Walker DH
Am J Trop Med Hyg; 2019 Nov; 101(5):1091-1095. PubMed ID: 31516114
[TBL] [Abstract][Full Text] [Related]
16. The Rickettsial Ankyrin Repeat Protein 2 Is a Type IV Secreted Effector That Associates with the Endoplasmic Reticulum.
Lehman SS; Noriea NF; Aistleitner K; Clark TR; Dooley CA; Nair V; Kaur SJ; Rahman MS; Gillespie JJ; Azad AF; Hackstadt T
mBio; 2018 Jun; 9(3):. PubMed ID: 29946049
[TBL] [Abstract][Full Text] [Related]
17. Cloned gene of Rickettsia rickettsii surface antigen: candidate vaccine for Rocky Mountain spotted fever.
McDonald GA; Anacker RL; Garjian K
Science; 1987 Jan; 235(4784):83-5. PubMed ID: 3099387
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immune responses of adults to vaccination, challenge with Rickettsia rickettsii, or both.
Dumler JS; Wisseman CL; Fiset P; Clements ML
Am J Trop Med Hyg; 1992 Feb; 46(2):105-15. PubMed ID: 1539743
[TBL] [Abstract][Full Text] [Related]
19. Extraction of protective components of Rickettsia rickettsii with n-octyl-beta-D-glucopyranoside.
McDonald GA; Anacker RL; Mann RE
Rev Infect Dis; 1988; 10 Suppl 2():S382-5. PubMed ID: 3142019
[TBL] [Abstract][Full Text] [Related]
20. Comparative genome sequencing of Rickettsia rickettsii strains that differ in virulence.
Clark TR; Noriea NF; Bublitz DC; Ellison DW; Martens C; Lutter EI; Hackstadt T
Infect Immun; 2015 Apr; 83(4):1568-76. PubMed ID: 25644009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]